These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 16595221

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oral contraceptives and insulin sensitivity.
    Cagnacci A.
    Fertil Steril; 2006 Jul; 86(1):e5; author reply e6. PubMed ID: 16750203
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP, Moran LJ.
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.
    Kahraman K, Sükür YE, Atabekoğlu CS, Ateş C, Taşkın S, Cetinkaya SE, Tolunay HE, Ozmen B, Sönmezer M, Berker B.
    Arch Gynecol Obstet; 2014 Aug; 290(2):321-8. PubMed ID: 24676694
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.
    Paoletti AM, Cagnacci A, Orrù M, Ajossa S, Guerriero S, Melis GB.
    Fertil Steril; 1999 Sep; 72(3):448-53. PubMed ID: 10519615
    [Abstract] [Full Text] [Related]

  • 12. Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
    Adeniji AA, Essah PA, Nestler JE, Cheang KI.
    J Womens Health (Larchmt); 2016 Jun; 25(6):638-45. PubMed ID: 26871978
    [Abstract] [Full Text] [Related]

  • 13. Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile.
    Creatsas G, Koliopoulos C, Mastorakos G.
    Ann N Y Acad Sci; 2000 Jun; 900():245-52. PubMed ID: 10818412
    [Abstract] [Full Text] [Related]

  • 14. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
    [Abstract] [Full Text] [Related]

  • 15. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C, Thaipisuttikul Y, Pinjaroen S, Krisanapan O, Benjawang W, Koster A, Doesburg W.
    Int J Fertil Menopausal Stud; 1996 Jan; 41(4):423-9. PubMed ID: 8894800
    [Abstract] [Full Text] [Related]

  • 16. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
    Lemay A, Dodin S, Turcot L, Déchêne F, Forest JC.
    Hum Reprod; 2006 Jan; 21(1):121-8. PubMed ID: 16199428
    [Abstract] [Full Text] [Related]

  • 17. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
    Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC.
    Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
    [Abstract] [Full Text] [Related]

  • 18. Oral contraceptives and insulin sensitivity.
    Cagnacci A.
    Fertil Steril; 2006 Aug; 86(2):495-6; author reply 496-7. PubMed ID: 16892490
    [No Abstract] [Full Text] [Related]

  • 19. [Efficacy and metabolic safety of long-term treatment with ethinyl oestradiol/cyproterone and desogestrel/ethinyl oestradiol tablets in women with polycystic ovary syndrome].
    Zhang J, Su M, Xu L, Yang Z, Yin W, Nie Y, Qiao X, Cheng R, Ma Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul 30; 38(8):917-922. PubMed ID: 30187872
    [Abstract] [Full Text] [Related]

  • 20. Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
    Koyuncu FM, Kuscu NK, Var A, Onur E.
    Acta Obstet Gynecol Scand; 2003 Aug 30; 82(8):767-8. PubMed ID: 12848650
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.